Day: July 17, 2021

Core One Labs to Present on its Proprietary Biosynthetic Psilocybin Technology at Investor Town Hall Event on August 4, 2021

Core One Labs to Present on its Proprietary Biosynthetic Psilocybin Technology at Investor Town Hall Event on August 4, 2021

VANCOUVER, British Columbia, July 17, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that Dr. Robert E.W. Hancock, the Company’s Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies Inc. (“Vocan”) will be presenting at a Company hosted Virtual Town Hall meeting on Wednesday, August 4, 2021 at 1:30 p.m. PST/ 4:30 p.m. ET/ 22:30 p.m. CET. The Virtual Town Hall event will comprise of a presentation by Dr. Hancock on the status of Vocan’s production of biosynthetic psilocybin and will include live video from the Company’s operating laboratory in Victoria, British Columbia. Dr. Hancock will also be answering questions from investors. “2021 has been a significant year for Core One Labs, and our teams have been very...

Continue reading

ECMOHO Announces Strategic Cooperation Agreement with South Korean ChongKunDang Group to Establish Distribution of High-End Health Foods

ECMOHO Announces Strategic Cooperation Agreement with South Korean ChongKunDang Group to Establish Distribution of High-End Health Foods

SHANGHAI, China, July 16, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the health and wellness market in China, is pleased today to announce a strategic cooperation agreement with well-known South Korean pharmaceutical company, ChongKunDang Group (hereafter referred to as “CKD”), in providing global marketing and multichannel sales for one-stop retail solutions for CKD’s health products in China. With advanced equipment and cutting-edge technology as its foundation, CKD will be able to provide Chinese consumers with high-quality, diversified healthcare products, including probiotics, via ECMOHO’s established and extensive domestic distribution channels. ECMOHO, as a leading online retail service provider of health products in China, has cooperated...

Continue reading

Ammonia Market to Reach USD 110.93 Billion by 2028; Essentiality of NH3 in Fertilizer Production to Foster Enduring Market Growth, Says Fortune Business Insights™

Ammonia Market to Reach USD 110.93 Billion by 2028; Essentiality of NH3 in Fertilizer Production to Foster Enduring Market Growth, Says Fortune Business Insights™

Key companies covered in the ammonia market are Rashtriya Chemicals and Fertilizers Limited (RCFL) (Mumbai, India), Praxair Technology, Inc. (Connecticut, the U.S.), EuroChem Group (Zug, Switzerland), SABIC (Riyadh, Saudi Arabia), CF Industries Holdings, Inc. (Illinois, the U.S.), Yara International ASA (Oslo, Norway), China National Petroleum Corporation (Beijing, China), Koch Fertilizer, LLC (Kansas, the U.S.), Qatar Petroleum (Doha, Qatar), Nutrien Ltd. (Saskatoon, Canada), BASF SE (Ludwigshafen, Germany) and more players profiled Pune, India, July 16, 2021 (GLOBE NEWSWIRE) — The global ammonia market size is projected to reach USD 110.93 billion by 2028, exhibiting a CAGR of 6.4%during the forecast period. As per the report by Fortune Business Insights™, titled “Ammonia Market, 2021-2028”, the market’s value was estimated to...

Continue reading

Monmouth Real Estate Investment Corporation Announces Receipt of Amendment to Unsolicited Acquisition Proposal

Monmouth Real Estate Investment Corporation Announces Receipt of Amendment to Unsolicited Acquisition Proposal

No Action Needs to be Taken by Monmouth Shareholders at This Time HOLMDEL, N.J., July 16, 2021 (GLOBE NEWSWIRE) — Monmouth Real Estate Investment Corporation (NYSE: MNR, “Monmouth” or “the Company”) today announced that it received an amendment to the unsolicited acquisition proposal it previously received on July 8, 2021 from a certain large private investment firm. The amendment to the proposal reflects an increase of $0.18 per share in the consideration that would be paid for each share of Monmouth Common Stock, resulting in a net cash consideration of $18.88 per share, reflecting a stated purchase price of $19.51 per share reduced by the termination fee of approximately $62.2 million, or $0.63 per share, if Monmouth terminates the merger agreement it previously entered into with Equity Commonwealth (“EQC”) in accordance with...

Continue reading